$ASPE
$12.76
Current Price
N/A
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 4 | 6 | $67,999,995.00 | 4,533,333 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 4 | 6 | $67,999,995.00 | 4,533,333 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 4 | 6 | $67,999,995.00 | 4,533,333 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 4 | 6 | $67,999,995.00 | 4,533,333 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 3 months | Buys | 4 | 6 | $67,999,995.00 | 4,533,333 | All Buys |
| Sells | 0 | 0 | - | - | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | Thompson Peter A. Director | Purchase | 1,000,000 | $15.00 | $15,000,000.00 | View Details |
| Nov 2, 2026 | ORBIMED ADVISORS LLC Director | Purchase | 1,000,000 | $15.00 | $15,000,000.00 | View Details |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. 10% Owner | Purchase | 66,667 | $15.00 | $1,000,005.00 | View Details |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. 10% Owner | Purchase | 66,666 | $15.00 | $999,990.00 | View Details |
| Nov 2, 2026 | ARCH Venture Fund X, L.P. 10% Owner | Purchase | 1,200,000 | $15.00 | $18,000,000.00 | View Details |
| Nov 2, 2026 | ARCH Venture Partners XIV, L.P. 10% Owner | Purchase | 1,200,000 | $15.00 | $18,000,000.00 | View Details |
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
No past earnings data available
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies:
$TRAW โ Traws Pharma, Inc.via ORBIMED ADVISORS LLC$QTTB โ Q32 Bio Inc.via ORBIMED ADVISORS LLC$PRLD โ Prelude Therapeutics Incvia ORBIMED ADVISORS LLC$STTK โ Shattuck Labs, Inc.via ORBIMED ADVISORS LLC$EWTX โ Edgewise Therapeutics, Inc.via Thompson Peter A.$ACET โ Adicet Bio, Inc.via ORBIMED ADVISORS LLC$MBX โ MBX Biosciences, Inc.via ORBIMED ADVISORS LLC$ADRX โ ADARx Pharmaceuticals, Inc.via ORBIMED ADVISORS LLC$BLSM โ BlossomHill Therapeutics, Inc.via ORBIMED ADVISORS LLC$SCTX โ Scribe Therapeutics, Inc.via ORBIMED ADVISORS LLC